Research and Development

Panu Miettinen, 43, has been appointed chief financial officer of Biotie Therapies.  He will become a member of the Group’s …

16 February 2012 – Medical Research Network (MRN), the unique Clinical Trial Support Organisation (CTSO) offering home trial support, site …

Michael Severino has been named senior vice president, Global Development and Corporate chief medical officer at Amgen.Severino, 46, formerly vice president, …

This year marks the 90th anniversary of the first ever successful use of insulin to treat patients with type I …

President Obama has unveiled a new budget which aims to cut the US deficit by $4 trillion over the next …

Biogen Idec will acquire the specialist immunology firm Stromedix for around $500 million. Biogen currently focuses on the development of …

Dr Andreas Menrad has joined the Belgium-based firm Ablynx as its new chief scientific officer. Dr Menrad has over 20 …

The European Medicines Agency has released an implementation plan for the pharmacovigilance legislation, which sets out milestone dates for different …

Premier Research Group has announced the appointment of Sean Russell to the position of vice president, marketing.In this position, Russell …

Contract research and consulting firm Quintiles has launched two new services to help pharma improve their chances of developing and …

Gene-based biopharmaceutical firm Oxford BioMedica has announced that Andrew Wood, chief financial officer, has stepped down from the board of Oxford …

 Chiltern International Limited (Chiltern), a global contract research organization (CRO), announced that Drs. Marcelo Piccirillo and Carlo Lanza have joined …

The European Medicines Agency (EMA) and the European Food Safety Authority (EFSA) have agreed to work closer together on areas …

GlaxoSmithKline has posted strong underlying growth for 2011, but warns of a tough year ahead.  The UK firm saw 4% …